IPATF - ImmunoPrecise antibody cocktail shows neutralizing activity versus Omicron BA.2 in lab test

ImmunoPrecise Antibodies (NASDAQ:IPA) said its antibody cocktail PolyTope TATX-03 showed strong neutralizing activity against Omicron subvariant BA.2 in lab test. In-vitro data showed that the BA.2 pseudovirus was neutralized with a potency comparable to the previously analyzed Omicron BA.1, showing continued consistency of the cocktail to potently neutralize SARS-CoV-2 variants, the company said in an April 20 release. "Once again, the remarkable and unprecedented endurance of our first-generation TATX-03 antibody cocktail demonstrates a unique ability to maintain neutralization potency against all concerning viral mutants, this time against the currently dominant Omicron sublineage BA.2 containing, yet again, unique mutations," said IPA Chief Scientific Officer Ilse Roodink. IPA +1.25% to $5.65 premarket April 20

For further details see:

ImmunoPrecise antibody cocktail shows neutralizing activity versus Omicron BA.2 in lab test